Media Centre
© Enthera. All rights reserved
Enthera Srl, Via Visconti di Modrone, 18, 20122 Milan, Italy
T: +39 02 49533580
E: info@entherapharmaceuticals.com
Enthera Srl, Via Visconti di Modrone, 18, 20122 Milan, Italy
T: +39 02 49533580
E: info@entherapharmaceuticals.com
This website uses only technical cookies and does not perform any profiling or collection of personal data through cookies. Simply browsing the website does not require the user’s consent.
Website by Instinctif Partners
Enthera Pharmaceuticals Appoints Filippo Canducci as Chief Medical Officer
/in Press ReleasesMilan, Italy, February 16, 2023 – Enthera Pharmaceuticals (“Enthera”), a biotech company developing first-in-class biologics for selected autoimmune conditions, today announces the appointment of Filippo Canducci MD, PhD as Chief Medical Officer. Dr. Canducci brings more than 20 years of experience in translational medicine, clinical research and drug development in inflammatory and autoimmune diseases. Prior […]
Enthera Pharmaceuticals nomina Aled Williams come amministratore delegato
/in Press ReleasesMilano, 4 maggio 2022 – Enthera Pharmaceuticals (“Enthera”), azienda biotecnologica che sviluppa farmaci biologici “first in class” per alcune malattie autoimmuni nelle quali è coinvolto un nuovo meccanismo di apoptosi, annuncia oggi la nomina di Aled Williams a amministratore delegato e membro del suo Consiglio di Amministrazione. Aled ha oltre venticinque anni di esperienza in posizioni […]
Enthera Pharmaceuticals Appoints Aled Williams as Chief Executive Officer
/in Press ReleasesMilan, Italy, 4 May 2022 – Enthera Pharmaceuticals (“Enthera”), a biotech company developing first-in-class biologics for selected autoimmune conditions based on the discovery of a novel apoptosis pathway, today announces the appointment of Aled Williams as Chief Executive Officer and member of its Board of Directors. Aled has over twenty-five years of experience as a senior […]